2024-11-15T14:47:50-06:00 2023-12-31 010523282 Berry Dunn McNeil & Parker LLC 2211 Congress St Portland ME 04102 990 2023-01-01 813327581 Advanced Regenerative Manufacturing Institute Inc ADVA 6036663905 400 Commercial St Manchester NH 03101 Jennifer MacDonald Chief Operating Officer 6036663905 2024-11-15 1 1 Barbara J McGuan CPA P00219457 2077752387 2024-11-15 2023 2024-10-15 13:58:12Z Maureen Toohey 400 Commercial St Manchester NH 03101 26819069 0 X https://www.armiusa.org/ X 2016 NH ARMI's mission is to support, develop, advance and promote the United States bioeconomy. 5 4 77 150 0 0 28539924 24486867 1511772 2229394 9695 102808 0 0 30061391 26819069 14140651 11333391 0 0 5185046 7026216 0 0 0 8174050 7950167 27499747 26309774 2561644 509295 28649661 29045430 11484704 11371178 17164957 17674252 X ARMI's mission is to support, develop, advance and promote the United States bioeconomy. 0 0 ARMI and its BioFabUSA Institute accomplishes its mission through key activities, such as the following:- Collaborates with community, local, State, and Federal stakeholders to advance the U.S bioeconomy and fuel inclusive economic growth, including by creating pathways and access to jobs in the biofabrication industry. - Provides wrap-around commercialization services for tissue engineering and enabling technology companies. These efforts de-risk and accelerate translation of impactful technologies to market. - Funds technical projects that address many of the common manufacturing challenges faced by companies in the field of tissue engineering. This will allow tissue engineering and enabling technology companies to focus their time and resources on product-specific challenges, moving the entire industry forward more quickly and efficiently. - Funds education and workforce development (EWD) projects that address the industry need for trained employees with a broad base of biomanufacturing skills and specific expertise. This pressing need can otherwise constrain the growth of tissue engineering and enabling technology companies. - In coordination with organizations in the field of regenerative manufacturing, develops roadmaps of technical and EWD needs for the field. These roadmaps guide the work of organizations in the field of regenerative manufacturing and guide the selection of projects. - Hosts, sponsors, and participates in conferences and workshops that convene organizations that support regenerative manufacturing. These events allow for shared learning related to technical, regulatory, workforce, and financial challenges and solutions. - Shares information about best practices and innovations in the field via various fora and online resources.NextFab accomplishes is mission through key activities, such as the following: - Develop commercial advisory and consulting programs designed to accelerate adoption of advanced technologies. - Provide shared facilities to accelerate advanced technologies. - Performs projects of interest to U.S. Department of Health and Human Services. 0 1 0 1 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 1 1 0 0 0 0 0 1 0 1 0 1 1 0 0 1 0 0 0 0 0 1 1 1 0 1 25 0 1 77 1 0 0 0 0 0 0 0 0 X 5 4 1 0 0 0 1 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X Thomas Deyak CPA 6036663905 400 Commercial St Manchester NH 03101 X Dean Kamen Executive Director 5.00 X X 0 0 0 Martine Rothblatt Board Member 1.00 X 0 0 0 John Abele Board Member 1.00 X 0 0 0 Jim Weinstein Board Member 1.00 X 0 0 0 Blake Moret Board Member 1.00 X 0 0 0 Maureen Toohey Deputy Executive Director 15.00 X 0 0 0 James Scott Chief Administrative Officer 15.00 X 0 0 0 Brendan Duffy Treasurer 1.00 X 0 0 0 Jennifer MacDonald Chief Operating Officer 40.00 X 257584 0 27874 Julie Lenzer Chief Innovation Officer 40.00 X 196065 0 24973 Richard McFarland Chief Regulatory Officer 40.00 X 194203 0 28756 Edward Gordon BioFab Chief Operating Officer 40.00 X 191771 0 43112 Karla Talanian Past Chief Workforce Development Officer 40.00 X 170291 0 4034 Michael Orrico BioFab Startup Lab Manager 40.00 X 166835 0 18170 1176749 0 146919 17 0 1 0 US Pharmacopeial Convention PO Box 21845 New York NY 100871845 Contractor - HHS Programs 400016 Nexight Group LLC 1100 Wayne Avenue Suite 1100 Silver Spring MD 20910 Contractor - HHS Programs 194962 Pluristyx 201 Elliott Ave West Ste 290 Seattle WA 98119 Contractor - DoD Programs 192008 Stefany Shaheen 77 South Street Portsmouth NH 03801 Contractor 146242 Celdara 16 Cavendish Court Lebanon NH 03766 Contractor - EDA Program 101130 5 23981837 505030 24486867 Membership Dues 541700 1076179 1076179 Management Fee Revenue 541700 712874 712874 Other Program Revenue 541700 440341 440341 2229394 102808 102808 26819069 2229394 0 102808 10702911 630480 285458 5676792 131731 489210 443025 55638 45000 1288760 29716 366339 433756 1037269 176395 666717 2141641 35646 Lab Materials and Suppl 1673290 26309774 224206 140238 9697118 8126955 4452276 6802994 398735 597427 16583628 5657543 10652869 10926085 119415 76975 3105042 2374756 28649661 29045430 6919240 5334402 1460422 2204573 1457447 3105042 2374756 11484704 11371178 X 17164957 17674252 17164957 17674252 28649661 29045430 509295 0 X 0 1 X 1 1 1 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 6614322 577130 6037192 9969306 5080413 4888893 10926085 Right-of-use Assets 2374756 2374756 Lease Obligations 2374756 2374756 X Part X, Line 2: ARMI, Inc. is a not-for-profit corporation, as described under Section 501(c)(6) of the Internal Revenue Code, exempt from federal and state income taxes on income related to the fulfillment of ARMI, Inc.'s mission. Accordingly, no income tax expense for ARMI, Inc. has been reported in these financial statements. 1 Israel 0 0 Grant NextFab US-Israel Bilateral HealthTech Hub Program (HHS-Directed) 630480 0 0 0 0 0 0 630480 0 630480 Israel Grant NextFab US-Israel Bilateral HealthTech Hub Program 630480 Wire transfer 0 0 1 0 0 0 0 0 0 Part I, Line 2: ARMI's monitoring level is dependent on a risk assessment, which is completed on all subawards. Based on this assessment, ARMI performed procedures that included, but were not limited to, the following: o development of a written Statement of Work o periodic conference calls to review progress related to the Statement of Work o review of all deliverables prior to approval of invoices 1 Advanced Silicon Group 173 Bedford Rd Lincoln MA 01773 422798997 121705 0 See Part IV Advanced Solutions Inc 1901 Nelson Miller Pkwy Louisville KY 40223 462396901 33022 0 See Part IV Applied Biosensors 2500 S State St D224 Salt Lake City UT 84115 462551284 40406 0 See Part IV Arizona State University PO Box 876011 Tempe AZ 852876011 943360412 501(c)(3) 142716 0 See Part IV Auburn University 208 M White Smith Hall 381 Mell Street Auburn University AL 368495110 636000724 501(c)(3) 60454 0 See Part IV Axogen Corp 13631 Progress Blvd Ste 400 Alachua FL 32615 411301878 103852 0 See Part IV Axonova Medical 3401 Grays Ferry Avenue Philadelphia PA 19146 474139191 46162 0 See Part IV BETA Technologies Inc 1150 Airport Dr South Burlington VT 05403 831276474 4795913 0 See Part IV ChromoLogic LLC 1225 S Shamrock Ave Monrovia CA 91016 203048938 56413 0 See Part IV Cornell University PO Box 22 Ithaca NY 148510022 150532082 501(c)(3) 185296 0 See Part IV Dartmouth College 11 Rope Ferry Rd 6210 Hanover NH 037551404 020222111 501(c)(3) 415319 0 See Part IV DEKA Integrated Solutions Corp 340 Commercial St Manchester NH 03101 205085384 450000 0 See Part IV DEKA Integrated Solutions Corp 340 Commercial St Manchester NH 03101 205085384 29949 0 See Part IV Epibone 95 Greene Street 3rd Floor Jersey City NJ 07302 800952869 183024 0 See Part IV Georgia Tech Research Corp PO Box 100117 Atlanta GA 30384 586002023 501(c)(3) 121720 0 See Part IV MxD USA 1415 North Cherry Ave Chicago IL 60642 800926174 501(c)(3) 1225324 0 See Part IV Organamet Bio 430 S Decatur Ave Montgomery AL 36104 872069268 26919 0 See Part IV Safi Biotherapeutics Inc One Broadway Ste 14 Cambridge MA 02142 842856932 91000 0 See Part IV Sciperio Inc 12151 Research Pkwy Suite 100 Orlando FL 32826 731528382 300000 0 See Part IV Standards Coordinating Body 100 Bureau Drive MS 8543 Bldg 224 Room A105 Gaithersburg MD 20899 020845002 501(c)(3) 29064 0 See Part IV Texas A&M Engineering Experiment 400 Harvey Mitchell Pkwy Ste 300 College Station TX 778454375 741974733 501(c)(3) 169828 0 See Part IV The General Hospital Corporation dba Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(c)(3) 215169 0 See Part IV Theradaptive 7495 New Horizon Way Suite 240 Frederick MD 21703 465406159 165866 0 See Part IV Trustees of Boston University 881 Commonwealth Ave Boston MA 02215 042103547 501(c)(3) 57435 0 See Part IV University of California Davis AR Lockbox PO BOX 741816 Los Angeles CA 900741816 946036494 501(c)(3) 291715 0 See Part IV University of Florida UF Biotility 14193 NW 119th Terrace Alachua FL 32615 596002052 501(c)(3) 398058 0 See Part IV University of New Hampshire 51 College Road Room 109 Durham NH 038243585 026000937 501(c)(3) 16530 0 See Part IV University of New Hampshire 51 College Road Room 109 Durham NH 038243585 026000937 501(c)(3) 138441 0 See Part IV University of Notre Dame 836a Grace Hall Notre Dame IN 46556 350868188 501(c)(3) 255227 0 See Part IV Virginia Polytechnic Institute 300 Turner St Suite 4200 Blacksburg VA 24061 546001805 501(c)(3) 155142 0 See Part IV Washington University 7425 Forsyth St St Louis MO 63105 430653611 501(c)(3) 131615 0 See Part IV WPI 100 Institute Rd Worcester MA 01609 042121659 501(c)(3) 86992 0 See Part IV X-Therma 625B Alfred Nobel Dr Hercules CA 94547 472474292 160878 0 See Part IV 17 14 Part I, Line 2: ARMI's monitoring level is dependent on a risk assessment, which is completed on all subawards. Based on this assessment, ARMI performed procedures that included, but were not limited to, the following: o development of a written Statement of Work o periodic conference calls to review progress related to the Statement of Work o review of all deliverables prior to approval of invoices Form 990, Schedule I, Part II, Purpose of Grant or Assistance 1. Advanced Silicon Group - Name of Organization or Government: Advanced Silicon Group - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 2. Advanced Solutions Inc. - Name of Organization or Government: Advanced Solutions Inc. - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 3. Applied Biosensors - Name of Organization or Government: Applied Biosensors - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 4. Arizona State University - Name of Organization or Government: Arizona State University - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 5. Auburn University - Name of Organization or Government: Auburn University - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a grant awarded by a private foundation 6. Axogen Corp. - Name of Organization or Government: Axogen Corp. - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 7. Axonova Medical - Name of Organization or Government: Axonova Medical - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 8. BETA Technologies, Inc. - Name of Organization or Government: Beta Technologies, Inc. - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a grant with the U.S. Dept of Health and Human Services (HHS). Acts as a project management resource and contracting vehicle for projects determined by HHS, including projects involving Congressionally-directed funding. 9. ChromoLogic LLC - Name of Organization or Government: ChromoLogic LLC - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 10. Cornell University - Name of Organization or Government: Cornell University - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 11. Dartmouth College - Name of Organization or Government: Dartmouth College - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 12. DEKA Integrated Solutions Corp - Name of Organization or Government: DEKA Integrated Solutions Corp - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a DoD-directed competitive process open to all Members. Project directly selected by DoD. 13. DEKA Integrated Solutions Corp - Name of Organization or Government: DEKA Integrated Solutions Corp - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 14. Epibone - Name of Organization or Government: Epibone - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 15. Georgia Tech Research Corp - Name of Organization or Government: Georgia Tech Research Corp - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 16. MxD - Name of Organization or Government: MxD USA - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a DoD-directed CARES Act program. Project directly selected by DoD. 17. Organamet Bio - Name of Organization or Government: Organamet Bio - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 18. Safi Biotherapeutics Inc - Name of Organization or Government: Safi Biotherapeutics Inc - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a DoD-directed competitive process open to all Members. Project directly selected by DoD. 19. Sciperio Inc - Name of Organization or Government: Sciperio Inc - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a DoD-directed competitive process open to all Members. Project directly selected by DoD. 20. Standards Coordinating Body - Name of Organization or Government: Standards Coordinating Body - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 21. Texas A&M Engineering Experiment - Name of Organization or Government: Texas A&M Engineering Experiment - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 22. The General Hospital Corporation - Name of Organization or Government: The General Hospital Corporation - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a grant with the U.S. Dept of HHS for the NextFab US-Israel Bilateral HealthTech Hub Program (HHS-Directed) 23. Theradaptive - Name of Organization or Government: Theradaptive - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 24. Trustees of Boston University - Name of Organization or Government: Trustees of Boston University - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 25. University of California, Davis - Name of Organization or Government: University of California, Davis - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 26. University of Florida - Name of Organization or Government: University of Florida - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority Form 990, Schedule I, Part II, Purpose of Grant or Assistance Continuation: 27. University of New Hampshire - Name of Organization or Government: University of New Hampshire - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a U.S. Air Force funded grant. Project directly selected during grant application process. 28. University of New Hampshire - Name of Organization or Government: University of New Hampshire - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority. 29. University of Notre Dame - Name of Organization or Government: University of Notre Dame - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 30. Virginia Polytechnic Institute - Name of Organization or Government: Virginia Polytechnic Institute - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 31. Washington University - Name of Organization or Government: Washington University - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a grant awarded by a private foundation 32. WPI - Name of Organization or Government: WPI - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 33. X-Therma - Name of Organization or Government: X-Therma - (h) Purpose of Grant or Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority 0 0 0 Jennifer MacDonald Chief Operating Officer 232584 0 25000 0 0 0 3269 0 24605 0 285458 0 0 0 Edward Gordon BioFab Chief Operating Officer 191771 0 0 0 0 0 8010 0 35102 0 234883 0 0 0 Richard McFarland Chief Regulatory Officer 194203 0 0 0 0 0 8005 0 20751 0 222959 0 0 0 Julie Lenzer Chief Innovation Officer 196065 0 0 0 0 0 8009 0 16964 0 221038 0 0 0 Michael Orrico BioFab Startup Lab Manager 166835 0 0 0 0 0 2962 0 15208 0 185005 0 0 0 Karla Talanian Past Chief Workforce Development Off 170291 0 0 0 0 0 2908 0 1126 0 174325 0 0 0 Part I, Line 7 During the calendar year 2023, a one time starting bonus of $25,000 was paid to Jennifer MacDonald and was approved by the Deputy Executive Director. See Part V Part V Part V X 1457447 1457447 0 0 1 1457447 See Part V See Part V 450000 Subaward See Part V See Part V See Part V 29949 Subaward See Part V 1890 Associates LLC See Part V 110992 See Part V 0 1881 Associates LLC See Part V 192198 See Part V 0 Five Forty N Assoc LLC See Part V 656032 See Part V 0 150 Dow Associates LLC See Part V 119407 See Part V 0 Sch L, Part II, Loans to and/or From Interested Persons: (a) Name of Person: Five-Forty North Associates, LLC(b) Relationship with Organization:Owned more than 35% by Executive Director, Dean Kamen(c) Purpose of Loan: As part of the lease agreement, Five Forty North Associates provided a non-interest bearing loan to ARMI to complete fit-up of the Institute's core facility due to cost escalation relating to supply chain challenges. Sch L, Part III, Grants or Assistance Benefiting Interested Persons: (a) Name of Person: DEKA Integrated Solutions Corp(b) Relationship Between Interested Person and Organization: Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Grant: $450,000(d) Type of Assistance: Subaward(e) Purpose of Assistance: Subaward pursuant to a DoD-directed competitive process open to all Members. Project directly selected by DoD.(a) Name of Person: DEKA Integrated Solutions Corp(b) Relationship Between Interest Person and Organization: Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Grant: $29,949(d) Type of Assistance: Subaward(e) Purpose of Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority Sch L, Part IV, Business Transactions Involving Interested Persons: (a) Name of Person: 1890 Associates, LLC(b) Relationship Between Interested Person and Organization:Owned more than 35% by Executive Director, Dean Kamen(d) Rent Paid. ARMI follows a process to ensure rent paid is at or below market rate. (a) Name of Person: 1881 Associates, LLC(b) Relationship Between Interested Person and Organization:Owned more than 35% by Executive Director, Dean Kamen(d) Rent Paid. ARMI follows a process to ensure rent paid is at or below market rate. (a) Name of Person: Five-Forty North Associates, LLC(b) Relationship Between Interested Person and Organization:Owned more than 35% by Executive Director, Dean Kamen(d) Rent Paid. ARMI follows a process to ensure rent paid is at or below market rate. (a) Name of Person: 150 Dow Associates, LLC(b) Relationship Between Interested Person and Organization:Owned more than 35% by Executive Director, Dean Kamen(d) Rent Paid,. ARMI follows a process to ensure rent paid is at or below market rate. Form 990, Part VI, Section A, line 2 James Scott and Brendan Duffy are employees of DEKA, a company owned by Dean Kamen. Maureen Toohey is a member of the Toohey Law Group. The Executive Director Dean Kamen, board member Martine Rothblattt, and board member John Abele are directors at Beta Technologies. The Executive Director Dean Kamen and Deputy Executive Director Maureen Toohey are directors at Sequel Med Tech. Form 990, Part VI, Section A, line 6 ARMI is a membership based organization consisting of organizations with interests and/or experience with regenerative medicine and manufacturing in the United States. Form 990, Part VI, Section B, line 11b Key members of management review and comment on the 990 and it is distributed to all board members prior to filing with the Internal Revenue Service. Form 990, Part VI, Section B, line 12c The conflict of interest policy is included on ARMI's internal server, and is posted online on its member portal. Any new employees or officers are provided a copy of this when joining ARMI. Any conflicts are to be reported to the Executive Director or ARMI legal counsel. Form 990, Part VI, Section C, line 19 Upon Request Form 990, Part VII, Section A: As part of its startup activities, per its proposal to the government, the Organization (ARMI) does not pay compensation to some of its officers. Instead, these officers are compensated by member organization DEKA, an unrelated third party, through a government cost share agreement between ARMI and DEKA. DEKA does not treat these compensation payments as a charitable contribution to ARMI; therefore, the compensation is not required to be shown on Part VII, Section A, Line 1a. ARMI Research Collaborative Inc 400 Commerical Street Manchester NH 03101 933222788 See Part VII NH 501(c)(3) Line 7 Advanced Regenerative Manufacturing Institute Inc 1 ARMI Bioindustries Corp 500 Commercial Street Manchester NH 03101 850883563 Biotech Manufacturing and Development Services NH Advanced Regenerative Manufacturing Institute Inc C 778717 250486 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 ARMI Bioindustries Corp Q 712874 FMV Form 990, Schedule R, Part II: (b) Primary activity: Non-profit foundation whose mission is to advance regenerative medicine and enabling technologies.